fepblue glp 1 2025 GLP-1 trends 2025: real-world data, patient outcomes & future therapies Weight - Blue Cross and

Cardoso P, Young KG, Nair ATN, et al

The oxidative stress-inducible cystine/glutamate gntiporter, system x c : Cystine supplier and beyond

In diabetic cardiomyopathy, an increase in lipid metabolism and a decrease in glucose metabolism disrupt the fatty acid and glucose balance

The research team found that participants with genetic makeup mimicking the effect of GLP-1 receptor agonists leads to reductions in both lean mass (whole-body fat-free mass and trunk fat-free mass) and body fat (whole-body fat mass, trunk fat percentage and body fat percentage)

They also delay gastric emptying, which increases feelings of fullness, reduces food cravings and appetite, and leads to weight loss